Abstract: The invention refers to the use of transforming growth factor-beta 1 (TGF-?1) inhibitor peptides or polynucleotides encoding said peptides for the prevention and/or treatment of corneal fibrosis and/or corneal haze.
Type:
Application
Filed:
February 21, 2011
Publication date:
December 13, 2012
Applicants:
DIGNA BIOTECH, S.I., PROYECTO DE BIOMEDICINA CIMA S.L.
Inventors:
Javier Dotor De Las Herrerias, Miguel Jose Maldonado Lopez